Ribonuclease and Thiazolidinedione Compounds and their Use in Methods to Treat Cancer

The present invention relates to methods and kits for the treatment of cancer. A novel drug combination comprising a ribonuclease compound and a thiazolidinedione compound has been identified as producing a synergistic cytotoxicity effect in cancer cells. Methods and kits pertaining to the co-administration of these compounds are discussed herein.

Attached files:


Patents:
WO 2,009,088,992

Inventor(s): RAMOS-NINO MARIA E [US]; LITTENBERG BENJAMIN [US]

Type of Offer: Licensing



« More Medical Patents

---